{"id":{"repo_id":"lsu-thes","oai_identifier":"oai:repository.lsu.edu:gradschool_dissertations-1880"},"canonical_url":"https://search.dev.ndltd.org/etd/lsu-thes/oai:repository.lsu.edu:gradschool_dissertations-1880","repository":{"repo_id":"lsu-thes","name":"Lousiana State University","base_url":"https://repository.lsu.edu/do/oai/"},"display":{"title":"The role of cysteine 230 and lysine 238 of biotin carboxylase in the deprotonation of biotin and synthesis of bisubstrate analogy inhibitor of carboxyltransferase","abstract":"Acetyl-CoA carboxylase catalyzes the first step in the synthesis of fatty acids. The Escherichia coli form of the enzyme consists of a biotin carboxylase protein, a biotin carboxyl carrier protein, and a carboxyltransferase protein. This enzyme uses the cofactor biotin as a carboxyl carrier. In order for the carboxylation of biotin to occur, biotin must be deprotonated at its N-1 position. It has been proposed that the active site residues cysteine 230 and lysine 238 act as an acid-base pair to deprotonate biotin. To test this hypothesis, site-directed mutagenesis was used to mutate cysteine 230 to alanine (C230A) and lysine 238 to glutamine (K238Q). Mutations at either residue resulted in a 50-fold increase in the Km for ATP. The C230A mutation had no effect on the formation of carboxybiotin, indicating that cysteine 230 does not play a role in the deprotonation of biotin. However, the K238Q mutation resulted in no formation of carboxybiotin, which showed that lysine 238 has a role in the carboxylation reaction. However, the pK value for lysine 238 was 9.4 or higher, suggesting lysine 238 is not a catalytic base. Thus, the results suggest that cysteine 230 and lysine 238 do not act as an acid-base pair in the deprotonation of biotin. A bisubstrate analog inhibitor of carboxyltransferase was synthesized by covalently linking biotin to Coenzyme A via an acyl bridge between the sulfur of Coenzyme A and the N-1 of biotin. The inhibitor was found to have an inhibition constant of 23 ± 2 ìM, which means it binds the enzyme 350-times tighter than biotin. The bisubstrate analog demonstrated competitive inhibition versus malonyl-CoA and noncompetitive inhibition versus biocytin. This is consistent with an ordered kinetic mechanism with malonyl-CoA binding first. A precursor to the inhibitor, chloroacylated biotin, was capable of inhibiting the differentiation of 3T3-L1 cells in a dose-dependent manner. Treatment with chloroacylated biotin resulted in a decrease in acetyl-CoA carboxylase activity and inhibited lipid accumulation. Our results support recent studies that indicate acetyl-CoA carboxylase may be a suitable target as an anti-obesity therapeutic.","abstract_html":"Acetyl-CoA carboxylase catalyzes the first step in the synthesis of fatty acids. The Escherichia coli form of the enzyme consists of a biotin carboxylase protein, a biotin carboxyl carrier protein, and a carboxyltransferase protein. This enzyme uses the cofactor biotin as a carboxyl carrier. In order for the carboxylation of biotin to occur, biotin must be deprotonated at its N-1 position. It has been proposed that the active site residues cysteine 230 and lysine 238 act as an acid-base pair to deprotonate biotin. To test this hypothesis, site-directed mutagenesis was used to mutate cysteine 230 to alanine (C230A) and lysine 238 to glutamine (K238Q). Mutations at either residue resulted in a 50-fold increase in the Km for ATP. The C230A mutation had no effect on the formation of carboxybiotin, indicating that cysteine 230 does not play a role in the deprotonation of biotin. However, the K238Q mutation resulted in no formation of carboxybiotin, which showed that lysine 238 has a role in the carboxylation reaction. However, the pK value for lysine 238 was 9.4 or higher, suggesting lysine 238 is not a catalytic base. Thus, the results suggest that cysteine 230 and lysine 238 do not act as an acid-base pair in the deprotonation of biotin. A bisubstrate analog inhibitor of carboxyltransferase was synthesized by covalently linking biotin to Coenzyme A via an acyl bridge between the sulfur of Coenzyme A and the N-1 of biotin. The inhibitor was found to have an inhibition constant of 23 ± 2 ìM, which means it binds the enzyme 350-times tighter than biotin. The bisubstrate analog demonstrated competitive inhibition versus malonyl-CoA and noncompetitive inhibition versus biocytin. This is consistent with an ordered kinetic mechanism with malonyl-CoA binding first. A precursor to the inhibitor, chloroacylated biotin, was capable of inhibiting the differentiation of 3T3-L1 cells in a dose-dependent manner. Treatment with chloroacylated biotin resulted in a decrease in acetyl-CoA carboxylase activity and inhibited lipid accumulation. Our results support recent studies that indicate acetyl-CoA carboxylase may be a suitable target as an anti-obesity therapeutic.","abstract_has_math":false,"creators":["Levert, Keith Logan"],"institution":"Biological Sciences","degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2002,"date_issued":"2002-01-01T08:00:00Z","date_published":"2002-01-01T08:00:00Z","updated_at":"2026-07-24T02:58:25Z","subjects":["N-ethylmaleimide","solvent isotope effects","CABI-CoA","enzymology","CABI"],"languages":[],"rights":["unrestricted","Release the entire work immediately for access worldwide."],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd-0416102-152847","https://repository.lsu.edu/gradschool_dissertations/881"],"render_values":[{"text":"etd-0416102-152847","href":null,"code":true},{"text":"https://repository.lsu.edu/gradschool_dissertations/881","href":"https://repository.lsu.edu/gradschool_dissertations/881","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.31390/gradschool_dissertations.881","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Levert, Keith Logan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2002-04-11"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2022-05-12T23:10:18Z"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Biological Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["N-ethylmaleimide","solvent isotope effects","CABI-CoA","enzymology","CABI"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["unrestricted","Release the entire work immediately for access worldwide."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd-0416102-152847","10.31390/gradschool_dissertations.881","https://repository.lsu.edu/gradschool_dissertations/881"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Acetyl-CoA carboxylase catalyzes the first step in the synthesis of fatty acids. The Escherichia coli form of the enzyme consists of a biotin carboxylase protein, a biotin carboxyl carrier protein, and a carboxyltransferase protein. This enzyme uses the cofactor biotin as a carboxyl carrier. In order for the carboxylation of biotin to occur, biotin must be deprotonated at its N-1 position. It has been proposed that the active site residues cysteine 230 and lysine 238 act as an acid-base pair to deprotonate biotin. To test this hypothesis, site-directed mutagenesis was used to mutate cysteine 230 to alanine (C230A) and lysine 238 to glutamine (K238Q). Mutations at either residue resulted in a 50-fold increase in the Km for ATP. The C230A mutation had no effect on the formation of carboxybiotin, indicating that cysteine 230 does not play a role in the deprotonation of biotin. However, the K238Q mutation resulted in no formation of carboxybiotin, which showed that lysine 238 has a role in the carboxylation reaction. However, the pK value for lysine 238 was 9.4 or higher, suggesting lysine 238 is not a catalytic base. Thus, the results suggest that cysteine 230 and lysine 238 do not act as an acid-base pair in the deprotonation of biotin. A bisubstrate analog inhibitor of carboxyltransferase was synthesized by covalently linking biotin to Coenzyme A via an acyl bridge between the sulfur of Coenzyme A and the N-1 of biotin. The inhibitor was found to have an inhibition constant of 23 ± 2 ìM, which means it binds the enzyme 350-times tighter than biotin. The bisubstrate analog demonstrated competitive inhibition versus malonyl-CoA and noncompetitive inhibition versus biocytin. This is consistent with an ordered kinetic mechanism with malonyl-CoA binding first. A precursor to the inhibitor, chloroacylated biotin, was capable of inhibiting the differentiation of 3T3-L1 cells in a dose-dependent manner. Treatment with chloroacylated biotin resulted in a decrease in acetyl-CoA carboxylase activity and inhibited lipid accumulation. Our results support recent studies that indicate acetyl-CoA carboxylase may be a suitable target as an anti-obesity therapeutic."]},{"key":"dc:title","label":"Title","values":["The role of cysteine 230 and lysine 238 of biotin carboxylase in the deprotonation of biotin and synthesis of bisubstrate analogy inhibitor of carboxyltransferase"]}]}],"canonical_facts":{"dc:creator":["Levert, Keith Logan"],"dc:date":["2002-04-11"],"dc:date.available":["2022-05-12T23:10:18Z"],"dc:description.abstract":["Acetyl-CoA carboxylase catalyzes the first step in the synthesis of fatty acids. The Escherichia coli form of the enzyme consists of a biotin carboxylase protein, a biotin carboxyl carrier protein, and a carboxyltransferase protein. This enzyme uses the cofactor biotin as a carboxyl carrier. In order for the carboxylation of biotin to occur, biotin must be deprotonated at its N-1 position. It has been proposed that the active site residues cysteine 230 and lysine 238 act as an acid-base pair to deprotonate biotin. To test this hypothesis, site-directed mutagenesis was used to mutate cysteine 230 to alanine (C230A) and lysine 238 to glutamine (K238Q). Mutations at either residue resulted in a 50-fold increase in the Km for ATP. The C230A mutation had no effect on the formation of carboxybiotin, indicating that cysteine 230 does not play a role in the deprotonation of biotin. However, the K238Q mutation resulted in no formation of carboxybiotin, which showed that lysine 238 has a role in the carboxylation reaction. However, the pK value for lysine 238 was 9.4 or higher, suggesting lysine 238 is not a catalytic base. Thus, the results suggest that cysteine 230 and lysine 238 do not act as an acid-base pair in the deprotonation of biotin. A bisubstrate analog inhibitor of carboxyltransferase was synthesized by covalently linking biotin to Coenzyme A via an acyl bridge between the sulfur of Coenzyme A and the N-1 of biotin. The inhibitor was found to have an inhibition constant of 23 ± 2 ìM, which means it binds the enzyme 350-times tighter than biotin. The bisubstrate analog demonstrated competitive inhibition versus malonyl-CoA and noncompetitive inhibition versus biocytin. This is consistent with an ordered kinetic mechanism with malonyl-CoA binding first. A precursor to the inhibitor, chloroacylated biotin, was capable of inhibiting the differentiation of 3T3-L1 cells in a dose-dependent manner. Treatment with chloroacylated biotin resulted in a decrease in acetyl-CoA carboxylase activity and inhibited lipid accumulation. Our results support recent studies that indicate acetyl-CoA carboxylase may be a suitable target as an anti-obesity therapeutic."],"dc:identifier":["etd-0416102-152847","10.31390/gradschool_dissertations.881","https://repository.lsu.edu/gradschool_dissertations/881"],"dc:rights":["unrestricted","Release the entire work immediately for access worldwide."],"dc:subject":["N-ethylmaleimide","solvent isotope effects","CABI-CoA","enzymology","CABI"],"dc:title":["The role of cysteine 230 and lysine 238 of biotin carboxylase in the deprotonation of biotin and synthesis of bisubstrate analogy inhibitor of carboxyltransferase"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"],"thesis:institution_name":["Biological Sciences"]},"updated_at":"2026-07-24T02:58:25Z"}